Učitavanje...
Localized microbubble cavitation-based antivascular therapy for improving HCC treatment response to radiotherapy
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide and the fastest growing malignancy in the United States. With a 5-year survival rate below 12%, effective therapies for HCC are needed. Current treatments for HCC include microwave and radiofrequency ablation, hi...
Spremljeno u:
| Izdano u: | Cancer Lett |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693746/ https://ncbi.nlm.nih.gov/pubmed/28969964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2017.09.037 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|